Myriad Genetics (MYGN)
NASDAQ:MYGN
Myriad Genetics (MYGN) Ownership Overview
6.53% Insiders
16.94% Mutual Funds
15.12% Other Institutional Investors
25.91% ETFs
35.50% Public Companies and
Individual Investors
The ownership structure of Myriad Genetics (MYGN) stock is a mix of institutional, retail, and individual investors. Approximately 57.97% of the company’s stock is owned by Institutional Investors, 6.53% is owned by Insiders, and 35.50% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 09, 2026 | xxxxxxxxxxxxx | $199600 | |
Feb 27, 2026 | xxxxxxxxxxxxx | $494487 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $185096 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $3720750 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $7423166 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,158,656 | Institution | 11.93% | 51,776,164 | |
| 5,432,802 | Institution | 5.81% | 25,208,201 | |
| 4,587,407 | Institution | 4.91% | 21,285,568 | |
| 3,950,010 | Institution | 4.22% | 18,328,046 | |
| 3,786,984 | Institution | 4.05% | 17,571,606 | |
| 1,373,473 | Institution | 1.47% | 6,372,915 | |
| 1,207,019 | Institution | 1.29% | 5,600,568 | |
| 1,133,735 | Institution | 1.21% | 5,260,530 | |
| 1,064,541 | Insider | 1.14% | 4,939,470 | |
| 1,030,890 | Institution | 1.10% | 4,783,330 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,786,984 | Institution | 4.05% | 17,571,606 | |
| 1,373,473 | Institution | 1.47% | 6,372,915 | |
| 1,133,735 | Institution | 1.21% | 5,260,530 | |
| 1,030,890 | Institution | 1.10% | 4,783,330 | |
| 1,004,639 | Institution | 1.07% | 4,661,525 | |
| 913,044 | Institution | 0.98% | 4,236,524 | |
| 692,517 | Institution | 0.74% | 3,213,279 | |
| 665,149 | Institution | 0.71% | 3,086,291 | |
| 610,576 | Institution | 0.65% | 2,833,073 | |
| 512,814 | Institution | 0.55% | 2,379,457 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,717,394 | Institution | 6.11% | 26,528,708 | |
| 2,776,877 | Institution | 2.97% | 12,801,403 | |
| 2,484,049 | Institution | 2.66% | 11,525,987 | |
| 2,275,670 | Institution | 2.43% | 10,559,109 | |
| 1,029,949 | Institution | 1.10% | 4,748,065 | |
| 860,817 | Institution | 0.92% | 3,994,191 | |
| 789,312 | Institution | 0.84% | 3,662,408 | |
| 637,904 | Institution | 0.68% | 2,959,875 | |
| 509,254 | Institution | 0.54% | 2,362,939 | |
| 507,334 | Institution | 0.54% | 2,354,030 |
FAQ
Who Owns Myriad Genetics (MYGN)?
According to the latest TipRanks data, approximately 15.12% of the company's stock is held by institutional investors, 6.53% is held by insiders, and 35.50% is held by retail investors.
What percentage of Myriad Genetics (MYGN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 15.12% of Myriad Genetics (MYGN) stock is held by institutional investors.
What percentage of Myriad Genetics (MYGN) stock is held by retail investors?
According to the latest TipRanks data, approximately 35.50% of Myriad Genetics (MYGN) stock is held by retail investors.
Who owns the most shares of Myriad Genetics (MYGN)?
iShares owns the most shares of Myriad Genetics (MYGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.